Delivery Order SPE2DB24D3013-SPE2DB26FFFWG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,356.25 to AmerisourceBergen Drug Corp for the supply of Aplenzin ER 174 mg tablets (30-count units) on May 8, 2025, with completion scheduled for May 9, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,789.82 to AmerisourceBergen Drug Corp for the supply of Aplenzin ER 174 mg tablets (30-count packaging) on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,531.68 to AmerisourceBergen Drug Corp for the supply of Aplenzin ER 348 mg tablets (30-count) on June 9, 2025, with an ultimate completion date of June 10, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $3,458.54 to AmerisourceBergen Drug Corp for the supply of Aplenzin ER 348 mg tablets (30-count package) on September 17, 2025, with completion targeted for September 18, 2025. This non-competitive delivery order was issued on a firm fixed-price basis and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's broader...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $11,629.80 for Aplenzin ER 348 mg tablets (30-count supply) under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. The award, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-set-aside competitive award. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Aplenzin ER 348 mg tablets in quantities of 30 units, with a contract ceiling value of $18,556.71. This firm fixed-price delivery order, which is expected to be completed by August 28, 2025, represents a non-set-aside competitively awarded procurement. The award will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,815.42, is for the delivery of APLENZIN ER 348 MG TABLET 30S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves...
- This is a $7,370.87 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of APLENZIN ER 348 MG TABLET 30S, a prescription medication. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide the pharmaceutical product Aplenzin ER 174 mg tablets. The contract has a ceiling value of $10,273.64 and a performance period through March 19, 2024. AmerisourceBergen Drug Corp is also the prime contractor on a separate indefinite delivery contract (IDC) with DLA Troop Support Medical,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,537.34 firm fixed-price delivery order is for the supply of APLENZIN ER 522 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of March 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division,...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB26FFFWGDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,340.74 to AmerisourceBergen Drug Corp for the supply of Aplenzin ER 174 mg tablets (30-count units) on October 27, 2025, with an ultimate completion date of October 28, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and will be performed at the vendor's Conshohocken, Pennsylvania location. Aplenzin is a brand-name antidepressant medication containing bupropion, an atypical antidepressant commonly used in military and veteran healthcare settings. This delivery order operates under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies a broad spectrum of medications and medical supplies to support military medical programs. The company's extensive federal contract portfolio demonstrates its capability to fulfill federal procurement requirements across multiple therapeutic domains, positioning it as a key supplier for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 10/27/25 |